PCA3 urine test shows promise for PCa detection
June 24th 2010A urine test that is under development appears to show significant specificity when used to detect prostate cancer, according to a multi-institution study from researchers in Colorado, Pennsylvania, New York, and Virginia presented at the AUA annual meeting in San Francisco.
Androgen deprivation plus radiation may become standard for PCa
June 10th 2010Continuous androgen deprivation plus external beam radiation therapy should be the standard treatment approach for men with locally advanced prostate cancer, researchers reported at the American Society of Clinical Oncology annual meeting in Chicago.
Death risk is low if prostate cancer hasn't progressed in 10 years
June 1st 2010Most biochemical recurrence of prostate cancer following radical prostatectomy occurs within 10 years, and patients who remain free from progression a decade postoperatively can be counseled that their risk of subsequent cancer-related morbidity and mortality is low.
Stress urinary incontinence surgery outcomes accurately assessed by questionnaire
June 1st 2010A simple, one-item questionnaire is easy to administer, correlates with other widely used subjective and objective measures, and can be used as an outcome measure to evaluate surgery for stress urinary incontinence.
Patients with CP/CPPS may be classified with new system
June 1st 2010Chronic prostatitis/chronic pelvic pain syndrome is a complex, heterogeneous syndrome in terms of etiology and symptoms, making its treatment difficult. Thus, a first step to improved management of these conditions is to better classify and stratify patients.
PCNL's status as gold-standard procedure affirmed by study
June 1st 2010Percutaneous nephrolithotomy is considered the gold standard for the removal of large renal stones. Until recently, however, the procedure's efficacy had not been verified by a clinical study as large as a gold-standard procedure would seem to require.
Proposed malpractice reforms' effects unclear
June 1st 2010A new study indicates that existing evidence is insufficient to show that most of the tort reforms sought-with the exception of caps on noneconomic damages-would be effective in reducing malpractice claims frequency and costs and defensive medicine, or improving the supply of health care services and quality of care.